Special Interest Groups
Special Interest Groups (SIGs) are communities of Pediatric Pharmacy Association members who are interested in sharing focused ideas, knowledge and experiences with others in a specific sub-specialty area. The SIGs are formal groups organized around a common interest area, offering the opportunity for ongoing interaction among professionals regarding a certain topic.
SIGs members use the following tools to connect.
- Organized discussions on the Internet, listservs, eCommunities, and Conference Calls
- Targeted content within our Electronic newsletters and web content
- In-person meetings during our Annual Conference each year.
Co-Chair: Lea Eiland, PharmD
Co-Chair: Kalen Manasco, PharmD
Board Liaison: Eloise Woodruff, PharmD
Staff Liaison: Matthew Helms, MA
Current Special Interest Groups
Chair: Amanda Capino, PharmD
Chair-elect: Sarah Smith, PharmD
The Academia SIG is for members of the Pediatric Pharmacy Association that educate and train pharmacy students and residents specifically about pediatric patient practice. Additionally, members contribute to the development of learners with an interest in pediatric pharmacy. Academic pharmacists use their clinical experience and knowledge along with scholarship to shape education and ultimately the future of pediatric pharmacy practice. The Academia SIG supports the development of educators through sharing of teaching methods and resources, providing mentorship, and opportunities for scholarship.
Chair: Kevin Lonabaugh, PharmD and Hanna Pratt, PharmD
According to the Board of Pharmacy Specialties, "ambulatory care pharmacy practice is the provision of integrated, accessible health care services by pharmacists who are accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community. This is accomplished through direct patient care and medication management for ambulatory patients, long-term relationships, coordination of care, patient advocacy, wellness and health promotion, triage and referral, and patient education and self-management. The ambulatory care pharmacists may work in both an institutional and community-based clinic involved in direct care of a diverse patient population." The Ambulatory Care SIG brings together members who practice in pediatric ambulatory care.
Chair: Josh Robinson, PharmD
Vice Chair: Amy Kiskaddon, PharmD
Pediatric pharmacists specializing in cardiology practice are members of interprofessional health care teams that care for a unique patient population in a variety of settings, including cardiovascular intensive care units (CVICU), medical wards, and specialty outpatient clinics. Clinical pharmacist services center around congenital heart disease, anticoagulation, arrhythmias, cardiac transplantation, mechanical circulatory support, and heart failure. Unlike many other pediatric specialties, these pharmacists work with the array of patients from premature neonates to geriatrics. They also contribute to the growing body of literature regarding optimal care in the cardiology, cardiac transplant, cardiac intensive care pediatric patient populations. The purpose of the Cardiology SIG is to bring members together who care for patients in these settings
Chair: Elizabeth J. Beckman, PharmD, BCPS, BCPPS, BCCCP
Vice-chair: Melissa A. Gervase, PharmD, BCPPS
According to the Board of Pharmacy Specialties, "critical care pharmacy practice specializes in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients. The practice requires informed, rapid assessment of clinical data for patients whose pharmacokinetic and pharmacodynamic parameters differ substantially from the non-critically ill patient. Pharmacists in this practice are required to review, analyze, and frequently reassess multifaceted clinical and technological information to make reasoned decisions for highly dynamic patients with life-threatening conditions and complex medication regimens." This SIG brings together members who practice in pediatric critical care.
Drug Information and Technology
Chair: Paul Paratore
Vice Chair: Karl Gumpper, PharmD
The DI and Technology SIG is for PPA members with an interest in drug information and/or technology use in pediatric patients. The goal of the SIG is to create an area for practitioners in drug information and informatics to have the opportunity to discuss topics and solve problems that are unique to pediatric patients. Members may currently be serving in administrative, research, operational, or clinical roles with a focus of using information to care for individual or groups of patients. In addition to supporting those with professional roles encompassing DI and informatics, the SIG also seeks to serve as a resource to those with questions and interests specific to these areas and connect them with experts in the field.
Emergency Medicine (ED)
Chair: Jenny Steinbrenner, PharmD
Vice Chair: Mary Riedy, PharmD
The emergency department (ED) provides a unique and evolving site for pharmacy practice. The main goal of pharmacists in this environment is to work as a part of the multidisciplinary team to increase medication safety while ensuring appropriate and timely medication administration during high-risk situations. As this practice area continues to develop, pediatric pharmacists are paving the way to create the ideal model to service patients in the emergency department. Pediatric ED pharmacists not only provide direct patient care such as medication order review, drug therapy monitoring and recommendations, and play a vital role in pediatric cardiopulmonary resuscitation, but also help with drug procurement, emergency preparedness, and ED-related quality improvement initiatives and research. The goal of the Emergency Medicine SIG is to bring together members who provide pharmacy services to patients in pediatric emergency departments.
Chair: Mindy Parman, PharmD
Vice Chair: Kristi Higgins, PharmD
The General Pediatric SIG is a group focused on topics found on a general pediatric unit. Some members in the group are general pediatric practice in stand alone children's hospitals while others are the sole pediatric pharmacist for their adult hospital with a few pediatric specific beds. Any pharmacist who participates in the general care of pediatrics will find benefit in our SIG.
Chair: Lola Afolabi, PharmD
Vice Chair: OPEN (email us if you are interested)
The GI/Nutrition is for members of the PPA who serve or interested in gastrointestinal and nutrition disorders afflicting pediatric patients such as inflammatory bowel diseases, short bowel diseases and patients on long term parenteral nutrition.
Chair: Andrew Clark, PharmD
Vice Chair: Jenn Le, PharmD
According to the Board of Pharmacy Specialties, hematology/oncology pharmacy specialists recommend, design, implement, monitor and modify pharmacotherapeutic plans to optimize outcomes in patients with hematologic and/or oncologic diseases. The Hematology/Oncology SIG brings together members who care for pediatric patients with hematologic and/or oncologic diseases.
Chair: Sarah Parsons, PharmD
Vice Chair: Mike Raschka, PharmD
The Infectious Disease SIG brings together members who practice in pediatric infectious disease settings. Whether an active member of an antimicrobial stewardship team, a pediatric infectious disease specialist, or a pediatric clinical pharmacist, the Infectious Disease SIG brings together members with a common interest and focus in infectious diseases. The ID SIG encourages collaboration and communication in regards to current practices, treatment guidelines, and emerging concepts in infectious disease.
Investigational Drug Service - NEW 2021
Chair: Susan Sorenson, PharmD
Vice Chair: Christopher Scobey, PharmD
The Investigational Drug Service SIG is for Pediatric Pharmacy Association members who participate in and support clinical research protocols. These individuals are a key cog in therapeutic research by being the link between clinical research and clinical care. They may be involved in a wide range of investigational product handling activities including purchasing, receiving, storing, accounting for, supporting order entry activities, preparing, and returning or destroying investigational products. These individuals are dedicated to providing the highest quality, comprehensive pharmaceutical support to help ensure protocol and regulatory compliance, institutional integrity, and patient safety. The Investigational Drug Service SIG aims to help support the continual education and development of pharmacists involved in clinical research protocols or those who would like to learn more about pediatric clinical research, through sharing of information and resources, providing mentorship, and facilitating discussions relevant to investigational product best practices and related matters
Leadership / Practice Management
Chair: Coutney Sweet, PharmD
Vice Chair: Sierra Stauber, PharmD
The Leadership SIG is for members interested in discussing topics related to leadership, clinical and operational management, and professional development. Members may be currently serving in pharmacy department or other leadership role or have aspirations of leading at some time in the future.
Chair: Hyun Kim, PharmD
Vice Chair: Casey Moore, PharmD
Pharmacists help healthcare practitioners keep patients safe by leading efforts to improve medication safety within institutions or care settings. They are responsible for educating, advocating, and leading improvement efforts to ameliorate the medication use process (procedures and systems used to provide medication therapy to patients such as medication procurement, storage, prescribing, transcribing, preparing, dispensing, administration, documentation, and monitoring). The PPA Medication Safety SIG brings together members who provide these services in a pediatric setting.
Chair: Jenni Barnes, PharmD
Vice Chair: Deb Bondi, PharmD
The Neonatology SIG is for PPA members who provide patient care to newborns and infants, which may range from extremely preterm neonates up to infants who are 12 months old. Neonatal pharmacists are experts in the developmental pharmacology of prematurity, medication safety issues related to drug administration of small doses, and the unique disease states and treatment regimens utilized in preterm and term infants. The Neonatal SIG brings together members who serve neonatal and infant patients and may also include prenatal management of the fetus. The goal of the Neonatology SIG is to foster communication, education and opportunities in any practice setting where neonates and infants are served.
Chair: Renad Abu-Sawwa, PharmD
Vice Chair: Justin Cole, PharmD
The Neurology SIG is for pharmacists who serve and manage medication therapy for patients of all age groups with neurological or neuropsychiatric diseases in both inpatient and outpatient clinical settings.
Chair: Nicole Omecene, PharmD
Vice Chair: Jen Hamner, PharmD
The New Practitioner SIG is for any PPA member who has been in practice for less than 5 years. The SIG focuses on supporting and celebrating new practitioners in their career development through presentation and leadership opportunities, professional development topics and discussions, supporting life-long learning through clinical pearls, and networking opportunities. Membership includes new practitioners in all types of positions ranging from community practice to hospital and even academic roles. This SIG also includes post-doctoral trainees (residents and fellows).
Chair: Noelle Leung, PharmD
Chair-elect: Morgan King, PharmD
The OB (Women's Health) SIG is for members who help provide care for pregnant and postpartum women in an inpatient or outpatient setting. This includes working with ambulatory clinics, inpatients, or caring for infants of lactating mothers.
Chair: Cameron McKinzie, PharmD
Vice Chair: Thomas Laudone, PharmD
The Public Health SIG is for members of the Pediatric Pharmacy Association that have a passion for protecting and improving the health of pediatric patients in their communities. Additionally, members participate in expanding the pediatric pharmacy presence on a global scale by collaborating with organizations to improve clinical practice and provide educational programs in other countries. The goal of the public health SIG is to advocate for pharmacy services to promote accessible and high-quality pediatric healthcare within our country and across the world.
Chair: Katie Hobart, PharmD
Vice Chair: Kristin Bohannon, PharmD
Pediatric pulmonary pharmacists serve children with respiratory needs in a variety of clinical settings, including acute care settings as well as outpatient clinics. Pulmonary pharmacists serve the interdisciplinary care team to support safe and effective medication use. Some of the disease states pulmonary pharmacists focus on may include asthma and cystic fibrosis, among other disease states. The Pulmonary SIG brings together members that care for pediatric pulmonary patients.
Residency Program Directors
Chair: Kelly S. Bobo, Pharm.D., MBA, BCPS, BCPPS
Vice Chair: Kelly Steidl PharmD. BCPPS
The Residency Program Director SIG is for PPA members who are responsible for pharmacy residency programs in a variety of roles including: Residency Program Directors, Residency Program Coordinators and Residency Preceptors in a pediatric setting. The goal of this SIG is to share ideas to improve residency programs and better resident education, including best practices, preceptor development and residency recruitment. The RPD SIG brings together PPA members who are responsible for and participate in the maintenance of pharmacy residency programs.